期刊文献+

胰腺癌细胞在二维和三维培养系统中的生长特性研究 被引量:4

Growth Characteristics of Pancreatic Cancer Cells in Two-or Three-Dimensional Culture Systems
原文传递
导出
摘要 目的探讨胰腺癌细胞在二维平面培养和三维培养(Ⅰ型胶原和细胞外基质胶)中的生长特性。方法将3株胰腺癌细胞株SW1990、PCT和ASPC-1分别采用上述3种培养方式进行培养,观察细胞生长形态。采用CCK-8法测定细胞生长曲线,采用乙醇固定碘化丙锭染色法检测细胞周期分布。结果细胞在二维平面培养系统中呈单层贴壁生长;在Ⅰ型胶原和细胞外基质胶中细胞形成多细胞球样体(multicellular spheroid,MCS),其生长速度较二维平面培养中的细胞慢。在二维平面培养中生长的SW1990、PCT和ASPC-1细胞的S期细胞的比例分别为(29.6±3.0)%、(33.6±2.1)%和(33.1±1.8)%,明显高于在Ⅰ型胶原中培养4 d和8 d形成的MCS的S期细胞比例〔(18.2±5.1)%、(14.5±3.2)%和(24.7±2.6)%〕,P<0.05,而G2/M期的细胞比例差异没有统计学意义(P>0.05)。在Ⅰ型胶原中培养4 d和8 d的SW1990和PCT细胞以及培养8 d的ASPC-1细胞的G0/G1期细胞比例明显高于其在二维平面培养中的细胞比例(P<0.05)。在Ⅰ型胶原中培养4 d的ASPC-1细胞和SW1990细胞的S期细胞比例明显高于其培养8 d的细胞比例(P<0.05)。结论不同的培养方式、培养介质对胰腺癌细胞的生长具有较大的影响。MCS三维培养系统能更好地模拟体内肿瘤细胞的生长状况。 Objective To investigate the growth characteristics of pancreatic cancer cells in the two-dimensional culture system(monolayer) and three-dimensional culture system(type Ⅰ collagen and extracellular matrix gel).Methods Three pancreatic cancer cell lines(SW1990,PCT,and ASPC-1) were cultured in monolayer,type Ⅰ collagen,and extracellular matrix gel,respectively.The growth patterns were observed,growth curves were detected by CCK-8 test,and the cell cycle distributions were analyzed by propidium iodide staining.Results In the two-dimensional culture system,cells grew in monolayer.In the type Ⅰ collagen and the ECM gel three-dimensional culture system,cells formed multicellular spheroids(MCS),of which the growth rates were slower than those of the cells in monolayer.The proportions of S phase of SW1990,PCT,and ASPC-1 cells in two-dimensional culture system were significantly more than those in the type Ⅰ collagen on 4 d and 8 d((29.6±3.0)% vs.(18.2±5.1)%,(33.6±2.1)% vs.(14.5±3.2)%,(33.1±1.8)% vs.(24.7±2.6)%;P〈0.05),while the difference of proportion of three cell lines in G2/M phase was not different between two-dimensional culture system and type Ⅰ collagen(P〈0.05).The proportions of G0/G1 phase of SW1990 and PCT cells cultured in the type Ⅰ collagen on 4 d and 8 d and ASPC-1 cells cultured in the type Ⅰ collagen on 4 d were significant more than those cultured in two-dimensional culture system(P〈0.05).The proportions of S phase of ASPC-1 cells and SW1990 cells cultured in the type Ⅰ collagen on 4 d were significant more than those cultured in the type Ⅰ collagen on 8 d(P〈0.05).Conclusions The characteristics of pancreatic cancer cells in two-dimensional and three-dimensional culture systems are different.MCS culture system can better mimic the in vivo growth environment of cells in tumors.
出处 《中国普外基础与临床杂志》 CAS 2011年第1期33-38,共6页 Chinese Journal of Bases and Clinics In General Surgery
基金 国家自然科学基金资助项目(项目编号:30772526) 北京市自然科学基金(项目编号:7092084)~~
关键词 胰腺癌 多细胞球样体 三维培养 Ⅰ型胶原 细胞外基质胶 生长曲线 细胞周期 Pancreatic cancer Multicellular spheroid Three-dimensional culture Type Ⅰ collagen Extracellular matrix gel Growth curve Cell cycle
  • 相关文献

参考文献27

  • 1Abbott A.Cell culture:biolog's new dimension[J].Na ture,2003,424(6951):870-872.
  • 2Matsuura,T.Bioreactors for 3-dimensional high-density culture of human cells[J].Hum Cell,2006,19(1):11-16.
  • 3Del Duca D.Werbowetski T,Del Maestro RF.Spheroid prepara tion from hanging drops:characterization of a model of brain tumor invasion[J].J Neurooncol,2004,67(3):295-303.
  • 4Lee GY,Kenny PA,Lee EH,et al.Three-dimensional culture models of normal and malignant breast epithelial cells[J].Nat Methods,2007,4(4):359-365.
  • 5Lin RZ,Chang HY.Recent advances in three dimensional multicellular sphcroid culture for biomedical research[J].Biotechnol J,2008,3(9-10):1172-1184.
  • 6周涛,胡亚,廖泉,赵玉沛.2种体外肿瘤细胞药敏检测方法的比较研究[J].中国普外基础与临床杂志,2008,15(11):825-828. 被引量:2
  • 7周涛,胡亚,廖泉,赵玉沛.胰腺癌多细胞团簇的化疗药物敏感试验[J].中华胰腺病杂志,2008,8(6):361-364. 被引量:1
  • 8Mellor HR,Ferguson DJ,Callaghan R.A model of quiescent tumor microregions for evaluating multicellular resistance to chemothcrapeutic drugs[J].Br J Cancer,2005,93(3):302-309.
  • 9Kunz-Schughart LA,Freyer JP,Hofstaedter F,et al.The use of 3-D cultures for high-throughput screening:the multicellular spheroid model[J].J Biomol Screen,2004,9(4):273-285.
  • 10Mu(e)llcr-Klieser W.Tumor biology and experimental therapeutics[J].Crit Rev Oncol Hematol,2000,36(2 3):123-139.

二级参考文献92

  • 1葛骁.医院基建工程项目进度与质量控制管理对策研究[J].居舍,2020,0(1):137-137. 被引量:8
  • 2Yasuda H, Takada T, Wada K, etal. A new in-vitro drug sen sitivity test (collagen gel droplet embedded-culture drug sensitivity test) in carcinomas of pancreas and biliary tract: possible clinical utility [J].J Hepatobiliary Pancreat Surg, 1998; 5 (3) : 261
  • 3Kobayashi H, Higashiyama M, Minamigawa K, et al. Exami-nation of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric endpoint quantification [J]. Jpn J Cancer Res, 2001; 92(2) : 203
  • 4Alley MC, Seudiero DA, Monks A, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay [J]. Cancer Res, 1988; 48(3):589
  • 5Yang J, Richards J, Bowman P, et al. Sustained growth and three dimensional organization of primary mammary tumor epithelial cells embedded in collagen gels [J].Proc Natl Acad Sci USA, 1979; 76(7) : 3401
  • 6Richards J, Larson L, Yang J, et al. Method for culturing mammary epithelial cells in a rat tail collagen gel matrix [J]. Methods Cell Sci, 19837 8(1) :31
  • 7Kawamura M, Gika M, Abiko T, et al. Clinical evaluation of chemosensitivity testing for patients with unresectable nonsmall cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST) [J~. Cancer Chemother Pharmacol, 2007; 59(4) : 507
  • 8Vaccarello L, Wang YL, Whiteside TL. Sustained outgrowth of autotumor-reactive T lymphocytes from human ovarian carcinomas in the presence of tumor necrosis factor alpha and interleukin2 [J].HumImmunol, 1990; 28(2):216
  • 9Sieuwerts AM, Klijn JG, Peters HA, et al. The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50 values and cell survival [J]. Eur J ClinChemClinBiochem, 1995; 33(11) :813
  • 10Fricker SP, Buckley RG. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents[J]. AnticancerRes, 1996; 16(6B):3755

共引文献20

同被引文献36

  • 1Han-Tso Lin,Shih-Hwa Chiou,Chung-Lan Kao,Yi-Ming Shyr,Chien-Jen Hsu,Yin-Wen Tarng,Larry L-T Ho,Ching-Fai Kwok,Hung-Hai Ku.Characterization of pancreatic stem cells derived from adult human pancreas ducts by fluorescence activated cell sorting[J].World Journal of Gastroenterology,2006,12(28):4529-4535. 被引量:15
  • 2Sundstrom L, Biggs T, Laskowski A, et al. OrganDots-an organo- typic 3D tissue culture platform for drug development [ J]. Expert Opin Drug Discov, 2012, 7(6) : 525-534.
  • 3Giaccone G, Herbst RS, Manegold C, et al. Gefitinib in combina- tion with gemcitabine and cisplatin in advanced non-small cell lung cancer: A phase Ⅲ trial-INTACT 1 [J]. J Clin Oncol, 2004, 22 (5) : 777-784.
  • 4Herbst RS, Giaccone G, Schiller JH, et al. Gefitinib in combina- tion with paclitaxel and carboplatin in advanced non-small cell lung cancer: A phase Ⅲ trial-INTACT 2 [J]. J Clin Oncol, 2004, 22(5): 785-794.
  • 5Cheng H, An SJ, Zhang XC, et al. In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines [ J ]. Cancer Chemother Pharmacol, 2011, 67 ( 3 ) : 637-646.
  • 6Yamamoto Y, Ito A, Kato M, et al. Preparation of artificial skele- tal muscle tissues by a magnetic force-based tissue engineering teehnique[J]. J Biosci Bioeng, 2009, 108(6) :538-543.
  • 7ho A, Jitsunobu H, Kawabe Y, et al. Construction of heterotypic ceil sheets by magnetic force-based 3-D cocuhure of ldepG2 and NIH3T3 ceils [J]. J Biosci Bioeng, 2007, 104(5): 371-378.
  • 8Kim ES, Hirsh V, Mok T, et al. Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): A randomised phase Ⅲ trial [ J ]. Lancet. 2008, 372 ( 9652 ) : 1809-1818.
  • 9Gatzemeier U, Pluzanska A, Szczesna A, et al. Phase Ⅲ study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small cell lung cancer: The tarceva lung cancer investigation trial [ J ]. J Clin Oncol, 2007, 25 (12) : 1545-1552.
  • 10Herbst RS, Prager D, Hermann R, et at. TRIBUTE: A phase Ⅲ trial of erlotinib hydrochlofide ( OSI-774 ) combined with carbopla- tin and paclitaxel chemotherapy in advanced non-small cell lung cancer [J]. J Clin Oncol, 2004, 23(25) : 5892-5899.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部